Shivom, a revolutionary new startup, has launched a new report detailing how it aims to transform the genomics landscape. The company allows users to take control of their DNA data and collaborate with others on a decentralized, blockchain powered platform.
Shivom, a blockchain powered startup with a focus on becoming the largest genomic data hub on the planet, has detailed how it plans to revolutionize the genomics industry. Through their platform, contributors will own their genomic data and control the right to access it, while receiving rewards if they choose to share it with pharmaceutical companies, healthcare facilities, and research institutes.
More information can be found at: https://shivom.io
The site explains that now is the time for concerted, community wide development for the genomical challenges of the coming decade. Currently, a few key players hold the monopoly on genomic data and make huge profits from selling it on to third parties, usually without sharing the earnings with the data donor.
Shivom believes that this is where they can help; through their revolutionary new genomics sharing platform. It is a unique and empowering project that will enable DNA data donors to collaborate with change makers in biotechnology, healthcare industries, and government ordained research institutes for the purposes of drug development and disease research.
By working with these groups, donors will be able to contribute to an unprecedented era of medical marvels. Shivom is at the forefront of this change, and aims to ensure that more people can take control of their DNA data and make an impact if they choose to share it.
The aim is to make Shivom the largest economic data hub on the planet. It is creating a full-fledged ecosystem on the blockchain, and will offer an open marketplace for healthcare providers to add their apps and services, alongside genomic data analytics and personalized medicine.
The Shivom ecosystem will allow users to transform genomic data into useable information, break down data silos, help accelerate clinical trials, and facilitate drug research and development.
This revolutionary approach means that the company is able to change the dynamics of the global healthcare market.
The company states: “We are utilizing the most advanced technologies including blockchain, cloud computing, genome sequencing, artificial intelligence, and big data analytics to bring medical genomics into a new era.”
Shivom envisions a future where healthcare is auditable, authenticated by mass collaboration, and guided by trust. Full details can be found on the URL above. Interested parties can get in touch using the contact details provided on site.
